Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 3
1954 5
1955 9
1956 6
1957 5
1958 3
1964 1
1965 14
1966 22
1967 24
1968 29
1969 24
1970 30
1971 33
1972 31
1973 35
1974 31
1975 11
1976 16
1977 16
1978 14
1979 18
1980 16
1981 19
1982 12
1983 25
1984 28
1985 18
1986 20
1987 17
1988 24
1989 15
1990 28
1991 28
1992 17
1993 21
1994 33
1995 26
1996 26
1997 36
1998 41
1999 43
2000 42
2001 31
2002 29
2003 46
2004 44
2005 45
2006 56
2007 56
2008 83
2009 69
2010 74
2011 91
2012 78
2013 90
2014 102
2015 95
2016 123
2017 102
2018 97
2019 90
2020 87
2021 72
2022 69
2023 51
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

2,420 results

Results by year

Filters applied: . Clear all
Page 1
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU. Cottin V, et al. Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST. Am J Respir Crit Care Med. 2022. PMID: 35969190 Free PMC article.
The committee proposes to identify CPFE as a syndrome, given the clustering of pulmonary fibrosis and emphysema, shared pathogenetic pathways, unique considerations related to disease progression, increased risk of complications (pulmonary hypertension, lung cancer, and/or mortal …
The committee proposes to identify CPFE as a syndrome, given the clustering of pulmonary fibrosis and emphysema, shared pathogenetic pathway …
Lung volume reduction for emphysema.
Shah PL, Herth FJ, van Geffen WH, Deslee G, Slebos DJ. Shah PL, et al. Lancet Respir Med. 2017 Feb;5(2):147-156. doi: 10.1016/S2213-2600(16)30221-1. Epub 2016 Sep 29. Lancet Respir Med. 2017. PMID: 27693408 Review.
Use of vapour thermal energy or a sclerosant might allow focal treatment but the unpredictability of the inflammatory response limits their current use. In this Review, we aim to summarise clinical trial evidence on lung volume reduction and provide guidance on pati …
Use of vapour thermal energy or a sclerosant might allow focal treatment but the unpredictability of the inflammatory response limits their …
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group. Criner GJ, et al. Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164. doi: 10.1164/rccm.201803-0590OC. Am J Respir Crit Care Med. 2018. PMID: 29787288 Free article. Clinical Trial.
RATIONALE: This is the first multicenter randomized controlled trial to evaluate the effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no collateral ventilation out to 12 months. ...CONCLUSIONS: Zephyr EBV provides clinically me …
RATIONALE: This is the first multicenter randomized controlled trial to evaluate the effectiveness and safety of Zephyr Endobr …
Lung volume reduction surgery versus endobronchial valves: a randomised controlled trial.
Buttery SC, Banya W, Bilancia R, Boyd E, Buckley J, Greening NJ, Housley K, Jordan S, Kemp SV, Kirk AJB, Latimer L, Lau K, Lawson R, Lewis A, Moxham J, Rathinam S, Steiner MC, Tenconi S, Waller D, Shah PL, Hopkinson NS; CELEB investigators. Buttery SC, et al. Eur Respir J. 2023 Apr 27;61(4):2202063. doi: 10.1183/13993003.02063-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36796833 Free PMC article. Clinical Trial.
BACKGROUND: Lung volume reduction surgery (LVRS) and bronchoscopic lung volume reduction (BLVR) with endobronchial valves can improve outcomes in appropriately selected patients with emphysema. However, no direct comparison data exist to inform clinical decision making in …
BACKGROUND: Lung volume reduction surgery (LVRS) and bronchoscopic lung volume reduction (BLVR) with endobronchial valves can improve outcom …
Pulmonary emphysema.
Hutchison DC. Hutchison DC. BMJ. 1994 Nov 12;309(6964):1244-5. doi: 10.1136/bmj.309.6964.1244. BMJ. 1994. PMID: 7888832 Free PMC article. No abstract available.
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers.
Dunican EM, Elicker BM, Henry T, Gierada DS, Schiebler ML, Anderson W, Barjaktarevic I, Barr RG, Bleecker ER, Boucher RC, Bowler R, Christenson SA, Comellas A, Cooper CB, Couper D, Criner GJ, Dransfield M, Doerschuk CM, Drummond MB, Hansel NN, Han MK, Hastie AT, Hoffman EA, Krishnan JA, Lazarus SC, Martinez FJ, McCulloch CE, O'Neal WK, Ortega VE, Paine R 3rd, Peters S, Schroeder JD, Woodruff PG, Fahy JV. Dunican EM, et al. Am J Respir Crit Care Med. 2021 Apr 15;203(8):957-968. doi: 10.1164/rccm.202006-2248OC. Am J Respir Crit Care Med. 2021. PMID: 33180550 Free PMC article.
These data provide rationale for targeting patients with mucus-high/emphysema-low COPD in clinical trials of mucoactive treatments.Clinical trial registered with www.clinicaltrials.gov (NCT01969344)....
These data provide rationale for targeting patients with mucus-high/emphysema-low COPD in clinical trials of mucoactive treatments. …
CT of emphysema.
Newell JD Jr. Newell JD Jr. Radiol Clin North Am. 2002 Jan;40(1):31-42, vii. doi: 10.1016/s0033-8389(03)00107-6. Radiol Clin North Am. 2002. PMID: 11813818 Review.
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, Broman G, Hillerdal G, Mal H, Pison C, Briault A, Downer N, Darwiche K, Rao J, Hübner RH, Ruwwe-Glosenkamp C, Trosini-Desert V, Eberhardt R, Herth FJ, Derom E, Malfait T, Shah PL, Garner JL, Ten Hacken NH, Fallouh H, Leroy S, Marquette CH; TRANSFORM Study Team *. Kemp SV, et al. Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543. doi: 10.1164/rccm.201707-1327OC. Am J Respir Crit Care Med. 2017. PMID: 28885054 Free article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy and safety of Zephyr EBVs in patients with heterogeneous emphysema and absence of collateral ventilation. METHODS: This was a prospective, multicenter 2:1 randomized controlled trial of EBVs plus standard of care or standard of c …
OBJECTIVES: To evaluate the efficacy and safety of Zephyr EBVs in patients with heterogeneous emphysema and absence of collateral ventilatio …
The history of COPD.
Petty TL. Petty TL. Int J Chron Obstruct Pulmon Dis. 2006;1(1):3-14. doi: 10.2147/copd.2006.1.1.3. Int J Chron Obstruct Pulmon Dis. 2006. PMID: 18046898 Free PMC article. Review.
Knowledge of the pathogenesis, course and prognosis, and new approaches to therapy have dramatically improved our understanding of this important clinical entity. Smoking cessation improves the early course of disease. ...
Knowledge of the pathogenesis, course and prognosis, and new approaches to therapy have dramatically improved our understanding of this impo …
Lung Volume Reduction in Pulmonary Emphysema.
Garner JL, Shah PL. Garner JL, et al. Semin Respir Crit Care Med. 2020 Dec;41(6):874-885. doi: 10.1055/s-0040-1702192. Epub 2020 May 20. Semin Respir Crit Care Med. 2020. PMID: 32434233 Review.
Endobronchial valve implantation has demonstrated comparable outcomes to LVRS in selected individuals and has recently received approvals by the National Institute of Clinical Excellence in the United Kingdom and the Food and Drug Administration in the United States of Ame …
Endobronchial valve implantation has demonstrated comparable outcomes to LVRS in selected individuals and has recently received approvals by …
2,420 results